| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |